The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...
from NDTV News - Topstories https://ift.tt/2FMnI1j
https://ift.tt/eA8V8J
Saturday, September 19, 2020
Home »
» Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda
0 comments:
Post a Comment